ABOS
Price
$1.16
Change
+$0.03 (+2.65%)
Updated
Jul 3 closing price
Capitalization
70.27M
43 days until earnings call
NMRA
Price
$0.82
Change
+$0.04 (+5.13%)
Updated
Jul 3 closing price
Capitalization
132.89M
37 days until earnings call
Interact to see
Advertisement

ABOS vs NMRA

Header iconABOS vs NMRA Comparison
Open Charts ABOS vs NMRABanner chart's image
Acumen Pharmaceuticals
Price$1.16
Change+$0.03 (+2.65%)
Volume$94.01K
Capitalization70.27M
Neumora Therapeutics
Price$0.82
Change+$0.04 (+5.13%)
Volume$389.87K
Capitalization132.89M
ABOS vs NMRA Comparison Chart in %
Loading...
ABOS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NMRA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ABOS vs. NMRA commentary
Jul 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ABOS is a Hold and NMRA is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 06, 2025
Stock price -- (ABOS: $1.16 vs. NMRA: $0.82)
Brand notoriety: ABOS and NMRA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ABOS: 27% vs. NMRA: 36%
Market capitalization -- ABOS: $70.27M vs. NMRA: $132.89M
ABOS [@Biotechnology] is valued at $70.27M. NMRA’s [@Biotechnology] market capitalization is $132.89M. The market cap for tickers in the [@Biotechnology] industry ranges from $310.37B to $0. The average market capitalization across the [@Biotechnology] industry is $2.38B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ABOS’s FA Score shows that 0 FA rating(s) are green whileNMRA’s FA Score has 1 green FA rating(s).

  • ABOS’s FA Score: 0 green, 5 red.
  • NMRA’s FA Score: 1 green, 4 red.
According to our system of comparison, NMRA is a better buy in the long-term than ABOS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ABOS’s TA Score shows that 5 TA indicator(s) are bullish while NMRA’s TA Score has 4 bullish TA indicator(s).

  • ABOS’s TA Score: 5 bullish, 5 bearish.
  • NMRA’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, both ABOS and NMRA are a good buy in the short-term.

Price Growth

ABOS (@Biotechnology) experienced а -4.13% price change this week, while NMRA (@Biotechnology) price change was +2.78% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +6.30%. For the same industry, the average monthly price growth was +17.40%, and the average quarterly price growth was -0.11%.

Reported Earning Dates

ABOS is expected to report earnings on Aug 18, 2025.

NMRA is expected to report earnings on Aug 12, 2025.

Industries' Descriptions

@Biotechnology (+6.30% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
NMRA($133M) has a higher market cap than ABOS($70.3M). ABOS YTD gains are higher at: -32.558 vs. NMRA (-92.249). ABOS has higher annual earnings (EBITDA): -111.98M vs. NMRA (-273.7M). NMRA has more cash in the bank: 249M vs. ABOS (149M). NMRA has less debt than ABOS: NMRA (938K) vs ABOS (29M). ABOS (0) and NMRA (0) have equivalent revenues.
ABOSNMRAABOS / NMRA
Capitalization70.3M133M53%
EBITDA-111.98M-273.7M41%
Gain YTD-32.558-92.24935%
P/E RatioN/AN/A-
Revenue00-
Total Cash149M249M60%
Total Debt29M938K3,092%
TECHNICAL ANALYSIS
Technical Analysis
ABOSNMRA
RSI
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
69%
Bullish Trend 4 days ago
78%
Momentum
ODDS (%)
Bearish Trend 4 days ago
90%
Bullish Trend 4 days ago
90%
MACD
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
89%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
88%
Bullish Trend 4 days ago
86%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
78%
Bullish Trend 4 days ago
87%
Advances
ODDS (%)
Bullish Trend 4 days ago
77%
N/A
Declines
ODDS (%)
Bearish Trend 10 days ago
88%
Bearish Trend 7 days ago
85%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
90%
Aroon
ODDS (%)
Bullish Trend 4 days ago
72%
Bullish Trend 4 days ago
86%
View a ticker or compare two or three
Interact to see
Advertisement
ABOS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NMRA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
UNRG0.04N/A
+11.38%
United Energy Corp.
JRONY54.081.90
+3.64%
Jeronimo Martins, SGPS, SA
EFIN43.00N/A
N/A
Eastern Michigan Financial Corp.
IGGRF12.33N/A
N/A
IG Group Holdings Plc.
OXBDF4.23N/A
N/A
Oxford Biomedica PLC

ABOS and

Correlation & Price change

A.I.dvisor indicates that over the last year, ABOS has been loosely correlated with CRBU. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if ABOS jumps, then CRBU could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ABOS
1D Price
Change %
ABOS100%
+2.65%
CRBU - ABOS
53%
Loosely correlated
N/A
FHTX - ABOS
53%
Loosely correlated
+3.64%
BEAM - ABOS
51%
Loosely correlated
+0.65%
CRSP - ABOS
50%
Loosely correlated
+0.97%
RXRX - ABOS
49%
Loosely correlated
+1.15%
More

NMRA and

Correlation & Price change

A.I.dvisor indicates that over the last year, NMRA has been loosely correlated with NGNE. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if NMRA jumps, then NGNE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NMRA
1D Price
Change %
NMRA100%
+5.04%
NGNE - NMRA
38%
Loosely correlated
+4.69%
ABOS - NMRA
37%
Loosely correlated
+2.65%
AURA - NMRA
36%
Loosely correlated
+1.55%
SNDX - NMRA
35%
Loosely correlated
N/A
INZY - NMRA
34%
Loosely correlated
N/A
More